Finally, because 80% of LGGs harbor IDH1 or IDH2 mono-allelic mutations [98], secondary GBMs (GBMs arising from previous LGGs) were often thought to be virtually always IDH mutant lower grade gliomas [21]. This evidence concerns the gene IDH1 and central nervous system cancer.